🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Glioblastoma (GBM) adaptive, global, innovative learning environment (GBM A...
Status
Recruiting
Location
University of Alabama at Birmingham
Start Date
2019-07-30
Trial ID
NCT03970447
This Phase I trial combines ADI-PEG 20 with docetaxel in patients with adva...
Status
Completed
Location
University of California at Davis
Start Date
2011-09-06
Trial ID
NCT01497925
Treatments Being Tested
Th purpose of this study is to determine whether ADI-PEG20 (PEGylated argin...
Status
Withdrawn
Location
Washington University School of Medicine
Start Date
2024-04-01
Trial ID
NCT05829239
Certain cancers require the amino acid arginine. Arginine deiminase (ADI) i...
Status
Completed
Location
MD Anderson
Start Date
2015-01-06
Trial ID
NCT01910012
Treatments Being Tested
RATIONALE: Pegylated arginine deiminase may stop the growth of tumor cells ...
Status
Completed
Location
University of Miami Sylvester Comprehensive Cancer Center - Miami
Start Date
2004-06
Trial ID
NCT00450372
Treatments Being Tested
This is an open label, intra-patient dose escalation, to evaluate ADI-PEG 2...
Status
Not Yet Recruiting
Location
University of California, San Francisco
Start Date
2026-03-09
Trial ID
NCT07389278
To compare the efficacy and safety in subjects with advanced or metastatic ...
Status
Terminated
Location
Mayo Clinic Arizona
Start Date
2023-11-29
Trial ID
NCT05712694
This is a study to determine the safety and toxicity of increasing doses of...
Status
Completed
Location
Northwestern University
Start Date
2001-09
Trial ID
NCT00029900
Treatments Being Tested
To compare the clinical outcomes of Lenvatinib treatment alone or Lenvatini...
Status
Unknown
Location
Chang Gung Memorial Hospital, Linkou branch
Start Date
2023-12-01
Trial ID
NCT06034977
Treatments Being Tested
Assessment of safety and tolerability of ADI-PEG 20 in combination with sor...
Status
Completed
Location
Memorial Sloan-Kettering Cancer Center
Start Date
2014-11
Trial ID
NCT02101593
Treatments Being Tested